Rheumatoid arthritis is linked to oral bacteria: etiological association

References

• Tatakis DN, Kumar PS. Etiology and pathogenesis of periodontal diseases. Dent Clin North Am. 2005;49:491–516.
   PubMedGoogle Scholar
• Greenwald RA, Kirkwood K. Adult periodontitis as a model for rheumatoid arthritis (with emphasis on treatment strategies). J Rheumatol. 1999;26:1650–3.
   PubMed Web of Science ®Google Scholar
• Mercado FB, Marshall RI, Klestov AC, Bartold PM. Relationship between rheumatoid arthritis and periodontitis. J Periodontol. 2001;72:779–87.
   PubMed Web of Science ®Google Scholar
• Rosenstein ED, Greenwald RA, Kushner LJ, Weissmann G. Hypothesis: the humoral immune response to oral bacteria pro-vides a stimulus for the development of rheumatoid arthritis. Inflammation. 2004;28:311–8.
   PubMed Web of Science ®Google Scholar
• Moen K, Brun JG, Madland TM, Tynning T, Jonsson R. Immu-noglobulin G and A antibody responses to Bacteroides forsythus and Prevotella intermedia in sera and synovial fluids of arthritis patients. Clin Diagn Lab Immunol. 2003;10:1043–50.
   Google Scholar
• Ogrendik M, Kokino S, Ozdemir F, Bird PS, Hamlet S. Serum antibodies to oral anaerobic bacteria in patients with rheumatoid arthritis. MedGenMed. 2005 Jun 16;7(2):2. http://www. medscape.com/viewarticle/505458. Accessed 16 June 2005.
   Google Scholar
• Moen K, Brun JG, Valen M, et al. Synovial inflammation in active rheumatoid arthritis and psoriatic arthritis facilitates trap-ping of a variety of oral bacterial DNAs. Clin Exp Rheumatol. 2006;24:656–63.
   PubMed Web of Science ®Google Scholar
• Ogrendik M, Hakguder A, Keser N. Treatment of rheumatoid arthritis with ornidazole. A randomized, double-blind, placebo-controlled study. Rheumatology (Oxford). 2006;45:636–7.
   Google Scholar
• Ogrendik M. Levofloxacin treatment in patients with rheumatoid arthritis receiving methotrexate. South Med J. 2007;100:135–9.
   Google Scholar
• Ogrendik M. Effects of clarithromycin in patients with active rheumatoid arthritis. Curr Med Res Opin. 2007;23:515–22.
   PubMed Web of Science ®Google Scholar
• Das KM. Sulfasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Am. 1989;18:1–20.
   PubMed Web of Science ®Google Scholar
• Amin AR, Attur MG, Thakker GD, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA. 1996;93:14014–9.
   PubMed Web of Science ®Google Scholar
• Tilley BC, Alarcon GS, Heyse SP, et al. Minocycline in rheu-matoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med. 1995;122: 81–9.
   Google Scholar
• Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BA. Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum. 1994;37:629–36.
   PubMed Web of Science ®Google Scholar
• O'Dell JR, Haire CE, Palmer W, et al. Treatment of early rheu-matoid arthritis with minocycline or placebo: results of a ran-domized, double-blind, placebo-controlled trial. Arthritis Rheum. 1997;40:842–8.
   PubMed Web of Science ®Google Scholar
• O'Dell JR, Paulsen G, Haire CE, et al. Treatment of early sero-positive rheumatoid arthritis with minocycline: four-year fol-lowup of a double-blind, placebo-controlled trial. Arthritis Rheum. 1999;42:1691–5.
   PubMed Web of Science ®Google Scholar
• Moreland LW, Baumgartner SW, Schiff MH, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med. 1997;337:141–7.
   PubMed Web of Science ®Google Scholar
• Seymour GJ, Gemmell E. Cytokines in periodontal disease: where to from here? Acta Odontol Scand. 2001;59:167–73.
   Google Scholar
• Yoshimura A, Hara Y, Kaneko T, Kato I. Secretion of IL-1 beta, TNF-alpha, IL-8 and IL- lra by human polymorphonuclear leu-kocytes in response to lipopolysaccharides from periodontopathic bacteria. J Periodontal Res. 1997;32:279–86.
   PubMed Web of Science ®Google Scholar
• Kjeldsen M, Holmstrup P, Lindemann RA, Bendtzen K. Bacte-rial-stimulated cytokine production of peripheral mononuclear cells from patients of various periodontitis categories. J Period-ontol. 1995;66:139–44.
   PubMed Web of Science ®Google Scholar
• Rossano F, Rizzo A, Sanges MR, Cipollaro de L'Ero G, Tufano MA. Human monocytes and gingival fibroblasts release tumor necrosis factor-alpha, interleukin-1 alpha and interleukin-6 in response to particulate and soluble fractions of Prevotella melaninogenica and Fusobacterium nucleatum. Int J Clin Lab Res. 1993;23: 165–8.
   Google Scholar
• Robinson AJ, Taylor DH, Wright GD. Infliximab therapy reduces periodontoid rheumatoid pannus formation. Rheumatology (Oxford). 2008;47:225–6.
   Google Scholar
• McGraw WT, Potempa J, Farley D, Travis J. Purification, char-acterization, and sequence analysis of a potential virulence factor from Porphyromonas gingivalis, peptidylarginine deiminase. Infect Immun. 1999;67:3248–56.
   PubMed Web of Science ®Google Scholar
• Gargiulo AV Jr, Robinson J, Toto PD, Gargiulo AW. Identifi-cation of rheumatoid factor in periodontal disease. J Periodontol. 1982;53:568–77.
   Google Scholar
• The J, Ebersole JL. Rheumatoid factor (RF) distribution in periodontal disease. J Clin Immunol. 1991;11:132–42.
   Google Scholar
• Tighe H, Carson DA. Rheumatoid factor. In: Ruddy S, Harris Jr. ED, Sledge CB, editors. Kelley's textbook of rheumatology. Philadelphia: WB Saunders; 2001. p. 151–60.
   Google Scholar
• Bonagura VR, Artandi SE, Davidson A, et al. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors. J Immunol. 1993; 151:3840–52.
   PubMed Web of Science ®Google Scholar
• Martin T, Crouzier R, Weber JC, Kipps TJ, Pasquali JL. Struc-ture-function studies on a polyreactive (natural) autoantibody. Polyreactivity is dependent on somatically generated sequences in the third complementarity-determining region of the antibody heavy chain. J Immunol. 1994;152:5988–96.
   Google Scholar
• Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978;298:869–71.
   PubMed Web of Science ®Google Scholar
• Katz J, Goultschin J, Benoliel R, Brautbar C. Human leukocyte antigen (HLA) DR4. Positive association with rapidly progress-ing periodontitis. J Periodontol. 1987;58:607–10.
   Google Scholar
• Gran JT, Husby G, Thorsby E. The association between rheu-matoid arthritis and HLA antigen DR4. Ann Rheum Dis. 1983;42: 292–6.
   Google Scholar
• Bonfil JJ, Dillier FL, Mercier P, et al. A "case control" study on the role of HLA DR4 in severe periodontitis and rapidly progressive periodontitis. Identification of types and subtypes using molecular biology (PCR.SSO). J Clin Periodontol. 1999;26:77–84.
   Google Scholar
• Lacki JK, Porawska W, Mackiewicz U, Mackiewicz S, Muller W. Changes in agalactosyl IgG levels correlate with radiological progression in early rheumatoid arthritis. Ann Med. 1996; 28:265–9.
   Google Scholar
• Haraldsson G, Meurman JH, Kononen E, Holbrook WP. Prop-erties of hemagglutination by Prevotella melaninogenica. Anaerobe. 2005;11:285–9.
   Web of Science ®Google Scholar
• Cuesta IA, Sud S, Song Z, Affholter JA, et al. T-cell receptor (V beta) bias in the response of rheumatoid arthritis synovial fluid T cells to connective tissue antigens. Scand J Rheumatol. 1997;26:166–73.
   Web of Science ®Google Scholar
• Hall FC, Thomson K, Procter J, McMichael AJ, Wordsworth BP. TCR beta spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes. Ann Rheum Dis. 1998;57:319–22.
   Google Scholar
• Leung KP, Tones BA. Prevotella intennedia stimulates expan-sion of Vbeta-specific CD4(+) T cells. Infect Immun. 2000; 68:5420–4.
   Web of Science ®Google Scholar
• Mathur A, Michalowicz B, Yang C, Aeppli D. Influence of periodontal bacteria and disease status on V beta expression in T cells. J Periodontal Res. 1995;30:369–73.
   Google Scholar
• Yoshida A, Nakano Y, Yamashita Y, et al. Immunodominant region of Actinobacillus actinomycetemcomitans 40-kilodalton heat shock protein in patients with rheumatoid arthritis. J Dent Res. 2001;80:346–50.
   PubMed Web of Science ®Google Scholar
• Ando T, Kato T, Ishihara K, Ogiuchi H, Okuda K. Heat shock proteins in the human periodontal disease process. Microbiol Immunol. 1995;39:321–7.
   Google Scholar
• Schett G, Redlich K, Xu Q, et al. Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) acti-vation in rheumatoid arthritis synovial tissue. Differential regu-lation of hsp70 expression and hsfl activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and anti-inflammatory drugs. J Clin Invest. 1998;102: 302–11.
   Google Scholar
• Clague RB, Firth SA, Holt PJ, Skingle J, Greenbury CL, Webley M. Serum antibodies to type II collagen in rheumatoid arthritis: comparison of 6 immunological methods and clinical features. Ann Rheum Dis. 1983;42:537–44.
   PubMed Web of Science ®Google Scholar
• Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum. 1994; 37:1023–9.
   Google Scholar
• Bedi GS, Williams T. Purification and characterization of a col-lagen-degrading protease from Porphyromonas gingivalis. J Biol Chem. 1994;269:599–606.
   PubMed Web of Science ®Google Scholar
• Backlund J, Carlsen S, Hoger T, et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA. 2002;99:9960–5.
   PubMed Web of Science ®Google Scholar
• Van den Steen PE, Proost P, Grillet B, et al. Cleavage of dena-tured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the sub-strate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002;16:379–89.
   PubMedGoogle Scholar
• Imamura T. The role of gingipains in the pathogenesis of peri-odontal disease. J Periodontol. 2003;74:111–8.
   PubMed Web of Science ®Google Scholar
• Andersen RB, Elling P. Immunofluorescent demonstration of intracellular fibrin in synovial tissue. Ann Rheum Dis. 1972;31:59–64.
   Google Scholar
• Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrul-linated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58:3009–19.
   PubMed Web of Science ®Google Scholar
• Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87–113.
   PubMed Web of Science ®Google Scholar
• Cardoso CR, Garlet GP, Crippa GE, et al. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease. Oral Microbiol Immunol. 2009;24:1–6.
   PubMedGoogle Scholar
• Kramer JM, Gaffen SL. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol. 2007;78:1083–93.
   PubMed Web of Science ®Google Scholar
• Oda T, Yoshie H, Yamazaki K. Porphyromonas gingivalis anti-gen preferentially stimulates T cells to express IL-17 but not receptor activator of NF-kappaB ligand in vitro. Oral Microbiol Immunol. 2003;18: 30–6.
   Google Scholar